GUIDELINES: Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statement
https://link.springer.com/article/10.1007/s12072-025-11023-x

ORIGINAL ARTICLE: Tirzepatide versus SGLT2 inhibitors for MASLD: a multi-institutional propensity score-matched cohort study
https://link.springer.com/article/10.1007/s12072-025-11021-z

ORIGINAL ARTICLE: TACE and tyrosine kinase inhibitors with or without PD-1 inhibitors as first-line therapy for intermediate-advanced HCC: a multicenter real-world cohort study
https://link.springer.com/article/10.1007/s12072-026-11052-0

ORIGINAL ARTICLE: Risk factors of adult recipient survival beyond 20 years since liver transplantation: retrospective cohort study
https://link.springer.com/article/10.1007/s12072-025-11029-5